| Drug Name: | Arbekacin (51025-85-5) |
|---|---|
| PubChem ID: | 123134305 |
| SMILES: | C1C[C@H]([C@H](O[C@@H]1CN)O[C@@H]2[C@H](C[C@H]([C@@H]([C@H]2O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)NC(=O)[C@H](CCN)O)N)N |
| InchiKey: | MKKYBZZTJQGVCD-WQPIBYOFSA-N |
| Therapeutic Category: | Anti-Infective Agents |
| Molecular Weight (dalton) | : | 552.626 |
| LogP | : | -6.3994 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 15 |
| Hydrogen Bond Donor Count | : | 11 |
| Total Polar Surface Area | : | 297.27 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category